Skip to main content

Find Clinical Trials

Home
Conditions
Biliary Tract Neoplasms

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

254 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Recruiting

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

NCT06877637

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations: Onkologimottagning Central Hospital in Kristianstad Kristianstad, Sweden

VE Onkologi Skåne University Hospital Lund, Sweden

VO kirurgi och gastroenterologi Skåne University Hospital Lund, Sweden

View Trial Details

Recruiting

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

NCT05285358

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

NCT05000294

Conditions: Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +50 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

NCT05874414

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

LACN Aneheim Flagship Office Los Angeles, California, United States

Orlando Health Orlando, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions: Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations: Advent Health Greenwood Village, Colorado, United States

Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States

Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States

Florida Hospital DeLand DeLand, Florida, United States

View all 42 locations

View Trial Details

Recruiting

Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study

NCT07636824

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Recruiting

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

NCT06274879

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +6 more
Locations: Inselspital Bern University Hospital Bern, Switzerland

Hôpitaux Universitaires Genève Geneva, Switzerland

Luzerner Kantonspital Lucerne, Switzerland

Universitätsspital Zürich Zurich, Switzerland

View Trial Details

Recruiting

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

NCT05655949

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Recruiting

EULAT Eradicate GBC

NCT06192719

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Cholelithiasis, +8 more
Locations: Hospital Papa Francisco Salta, Argentina

Sanatorio el Carmen Salta, Argentina

Hospital Pablo Soria San Salvador de Jujuy, Argentina

Complejo Hospitalario Viedma Cochabamba, Bolivia

View all 36 locations

View Trial Details

Recruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT06715839

Conditions: Appendiceal Neoplasms, Appendix Cancer, Bile Duct Carcinoma, +46 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China

View Trial Details